Time-to-event model-assisted designs for dose-finding trials with delayed toxicity
Time-to-event model-assisted designs for dose-finding trials with delayed toxicity
Summary Two useful strategies to speed up drug development are to increase the patient accrual rate and use novel adaptive designs. Unfortunately, these two strategies often conflict when the evaluation of the outcome cannot keep pace with the patient accrual rate and thus the interim data cannot be observed in …